Dulaglutide, Semaglutide, and Tirzepatide: How Do Gastrointestinal Adverse Effects Compare?

Annals on Call

In this episode of Annals On Call, Dr. Centor discusses the comparative risk for severe gastrointestinal adverse events associated with dulaglutide, semaglutide, and tirzepatide with Dr. Wajd Alkabbani.

First, listen to the podcast. After listening, ACP members can take the CME/MOC quiz for free.

CME/MOC:

Up to 1 AMA PRA Category 1 Credits™ and MOC Points
Expires January 20, 2029   active

Cost:

Free to Members

Format:

Podcasts and Audio Content

Product:

Annals on Call

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.